These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34286950)

  • 1. Biomimetic-Coated Nanoplatform with Lipid-Specific Imaging and ROS Responsiveness for Atherosclerosis-Targeted Theranostics.
    Ma B; Xu H; Wang Y; Yang L; Zhuang W; Li G; Wang Y
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35410-35421. PubMed ID: 34286950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ROS Responsive Nanoplatform with Two-Photon AIE Imaging for Atherosclerosis Diagnosis and "Two-Pronged" Therapy.
    Ma B; Xu H; Zhuang W; Wang Y; Li G; Wang Y
    Small; 2020 Nov; 16(45):e2003253. PubMed ID: 33078569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROS responsive nanoparticles loaded with lipid-specific AIEgen for atherosclerosis-targeted diagnosis and bifunctional therapy.
    Xu H; She P; Ma B; Zhao Z; Li G; Wang Y
    Biomaterials; 2022 Sep; 288():121734. PubMed ID: 35999079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive Oxygen Species Responsive Theranostic Nanoplatform for Two-Photon Aggregation-Induced Emission Imaging and Therapy of Acute and Chronic Inflammation.
    Ma B; Xu H; Zhuang W; Wang Y; Li G; Wang Y
    ACS Nano; 2020 May; 14(5):5862-5873. PubMed ID: 32379416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hierarchical Responsive Nanoplatform with Two-Photon Aggregation-Induced Emission Imaging for Efficient Cancer Theranostics.
    Ma B; Zhuang W; Xu H; Li G; Wang Y
    ACS Appl Mater Interfaces; 2019 Dec; 11(50):47259-47269. PubMed ID: 31769279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive Oxygen Species-Responsive Nanoparticle Delivery of Small Interfering Ribonucleic Acid Targeting Olfactory Receptor 2 for Atherosclerosis Theranostics.
    Ni H; Zhou H; Liang X; Ge Y; Chen H; Liu J; Wang B; Chen H; Zhang Y; Luo S; Chen Y; Lu X; Yin C; Fan Q
    ACS Nano; 2024 Aug; 18(34):23599-23614. PubMed ID: 39141682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species-responsive nano-platform with dual-targeting and fluorescent lipid-specific imaging capabilities for the management of atherosclerotic plaques.
    He Z; Chen Q; Duan X; Zhong Y; Zhu L; Mou N; Yang X; Cao Y; Han Z; He H; Wu S; Wang G; Qin X; Qu K; Zhang K; Liu J; Wu W
    Acta Biomater; 2024 Jun; 181():375-390. PubMed ID: 38734284
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Dong Y; Du P; Liu P
    Int J Pharm; 2020 Oct; 588():119723. PubMed ID: 32755688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red Blood Cell Membrane Spontaneously Coated Nanoprodrug Based on Phosphatidylserine for Antiatherosclerosis Applications.
    Cao Y; Han Z; Zhu L; He Z; Mou N; Duan X; Chen Q; Qin X; Zhang K; Qu K; Zhong Y; Wu W
    ACS Appl Mater Interfaces; 2024 Sep; 16(35):46578-46589. PubMed ID: 39172072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity.
    Wang Y; Li L; Zhao W; Dou Y; An H; Tao H; Xu X; Jia Y; Lu S; Zhang J; Hu H
    ACS Nano; 2018 Sep; 12(9):8943-8960. PubMed ID: 30114351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis.
    Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J
    Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines.
    Gao C; Huang Q; Liu C; Kwong CHT; Yue L; Wan JB; Lee SMY; Wang R
    Nat Commun; 2020 May; 11(1):2622. PubMed ID: 32457361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted nanoparticles triggered by plaque microenvironment for atherosclerosis treatment through cascade effects of reactive oxygen species scavenging and anti-inflammation.
    Luo X; Zhang M; Dai W; Xiao X; Li X; Zhu Y; Shi X; Li Z
    J Nanobiotechnology; 2024 Jul; 22(1):440. PubMed ID: 39061065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy.
    Ren H; Liu J; Li Y; Wang H; Ge S; Yuan A; Hu Y; Wu J
    Acta Biomater; 2017 Sep; 59():269-282. PubMed ID: 28663143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostics of atherosclerosis by the indole molecule-templated self-assembly of probucol nanoparticles.
    Chen F; Chen J; Han C; Yang Z; Deng T; Zhao Y; Zheng T; Gan X; Yu C
    J Mater Chem B; 2021 May; 9(20):4134-4142. PubMed ID: 33972981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shear stress and ROS-responsive biomimetic micelles for atherosclerosis via ROS consumption.
    Shen M; Li H; Yao S; Wu X; Liu S; Yang Q; Zhang Y; Du J; Qi S; Li Y
    Mater Sci Eng C Mater Biol Appl; 2021 Jul; 126():112164. PubMed ID: 34082967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Theranostics of Atherosclerosis by Dual-Responsive Nanoplatform via Photoacoustic Imaging and Three-In-One Integrated Lipid Management.
    Ma B; Xiao Y; Lv Q; Li G; Wang Y; Fu G
    Adv Mater; 2023 Feb; 35(5):e2206129. PubMed ID: 36394179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A ROS-responsive multifunctional targeted prodrug micelle for atherosclerosis treatment.
    Zhou Z; Liu Y; Xie P; Yin Z
    Int J Pharm; 2024 Jul; 660():124352. PubMed ID: 38901540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
    Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
    Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
    Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
    Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.